ARCHIVES

Interview With Departing NCI Director; Advice To His Successor.

This article is from The Cancer Letter archive.

Vol. 36 No. 26 | July 9, 2010

Download PDF Visit The Full Archive

Related Articles

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

PhRMA’s New Ethics Code Prohibits Trinkets, Dinners; Speaking Fees Still OK.

July 11, 2008

Center Core Grant Guidelines Changes Approved By NCAB

February 13, 1981

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought

July 27, 1984